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Clinical PerspectiveWhat Is New?Xirp2‐null hearts exhibited prolonged PR and QT intervals, slow conduction velocity, atrioventricular conduction block, and an abnormal infranodal ventricular conduction system.Xirp2‐null cardiomyocytes showed altered action potential waveform, partly explained by ionic current defects and protein interaction.Sixteen *XIRP* rare variants (6 were in silico predicted as deleterious) were identified in sudden unexplained nocturnal death syndrome victims, and 4 *XIRP* rare variants (2 were in silico predicted as deleterious) were detected in Brugada syndrome patients.Among these 20 variants, 2 likely pathogenic variants---a nonsense variant and a frameshift variant---were detected.What Are the Clinical Implications?Genetic screening of *XIRP* genes should be encouraged for clinical cardiac conduction defect patients and sudden cardiac death victims.The present study raises a possibility that the altered electrophysiology characteristics of XIRP‐null hearts may represent a potential target spot for cardiac conduction defect patients caused by *XIRP* mutation.

 {#jah32835-sec-0008}

For 100 years, sudden unexplained nocturnal death syndrome (SUNDS) has remained an autopsy negative enigma with uncertain etiology to both forensic pathologists and clinicians. The definition of SUNDS described an entity with a special clinic phenotype, which was reported in Southeast Asia[1](#jah32835-bib-0001){ref-type="ref"}, [2](#jah32835-bib-0002){ref-type="ref"}, [3](#jah32835-bib-0003){ref-type="ref"}, [4](#jah32835-bib-0004){ref-type="ref"}, [5](#jah32835-bib-0005){ref-type="ref"}, [6](#jah32835-bib-0006){ref-type="ref"}, [7](#jah32835-bib-0007){ref-type="ref"}, [8](#jah32835-bib-0008){ref-type="ref"} and the United States[9](#jah32835-bib-0009){ref-type="ref"}, [10](#jah32835-bib-0010){ref-type="ref"}, [11](#jah32835-bib-0011){ref-type="ref"}: (1) prevails preponderantly in males (\>90%); (2) \>80% of victims are aged between 20 and 40 years; (3) predominantly occurs in Southeast Asia or immigrants from Southeast Asia (such as Hmong in the United States) without a significant disease history; (4) occurs during nocturnal sleep with typical symptoms such as moaning and tachypnea; and (5) there are no pathological changes to identify the cause of death.

Previous evidence has shown that SUNDS might be a cardiac arrhythmia disease sharing overlapping genetic predisposition with Brugada syndrome (BrS) and long QT syndrome.[3](#jah32835-bib-0003){ref-type="ref"}, [4](#jah32835-bib-0004){ref-type="ref"}, [12](#jah32835-bib-0012){ref-type="ref"}, [13](#jah32835-bib-0013){ref-type="ref"} However, our postmortem genetic tests on the known lethal cardiac arrhythmia‐associated 39 genes could only possibly account for a small part of the genetic cause of SUNDS victims,[14](#jah32835-bib-0014){ref-type="ref"}, [15](#jah32835-bib-0015){ref-type="ref"}, [16](#jah32835-bib-0016){ref-type="ref"}, [17](#jah32835-bib-0017){ref-type="ref"}, [18](#jah32835-bib-0018){ref-type="ref"}, [19](#jah32835-bib-0019){ref-type="ref"} leaving unclear the genetic etiology of more than 80% of SUNDS cases. Thus, there is a pressing need to identify new susceptibility genes for SUNDS. Because SUNDS shares overlapping genetic causes with BrS, establishing new candidate genes may also expand the list of susceptible genes for this more‐prevalent arrhythmic disease.

The Xin actin‐binding repeat containing family of genes (*XIRPs*) are promising candidates for SUNDS. The XIRPs are localized to the intercalate discs (ICDs) of cardiomyocytes and have been shown to play important roles for postnatal ICD development and function.[20](#jah32835-bib-0020){ref-type="ref"} ICDs are responsible for mechanical and electrical coupling and transducing signals among cardiomyocytes.[20](#jah32835-bib-0020){ref-type="ref"} Genetic variants in ICD‐associated genes lead to cardiomyopathy, arrhythmias, and heart failure in both human patients and various genetically engineered animal models.[21](#jah32835-bib-0021){ref-type="ref"}, [22](#jah32835-bib-0022){ref-type="ref"}, [23](#jah32835-bib-0023){ref-type="ref"}, [24](#jah32835-bib-0024){ref-type="ref"}, [25](#jah32835-bib-0025){ref-type="ref"} Diverse vertebrates, including mammals, possess 2 paralogous genes encoding the XIRP proteins, *XIRP1* (*Xin*α or *CMYA1*) and *XIRP2* (*Xin*β or *CMYA3*).[26](#jah32835-bib-0026){ref-type="ref"} Deletion of mouse *Xirp1* (*mXin*α) leads to late‐onset cardiomyopathy with conduction and structural defects in ICDs,[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"}, [30](#jah32835-bib-0030){ref-type="ref"} whereas complete loss of mouse *Xirp2* (*mXin*β) results in the failure in ICD maturation, severe growth retardation, and early postnatal lethality.[31](#jah32835-bib-0031){ref-type="ref"}

We have shown that Xirp1 plays important roles in maintaining the electrophysiological functions in the heart. Loss of Xirp1 in ventricular cardiomyocytes leads to significantly reduced transient outward K^+^ current (I~TO~) and delayed rectifier K^+^ current (I~K~).[27](#jah32835-bib-0027){ref-type="ref"} Consistently, *Xirp1* ^*−/−*^ ventricular and left atrial‐pulmonary vein cardiomyocytes have prolonged action potential duration (APD), less‐negative maximal diastolic potential, and increased incidence of early afterdepolorization, which may underlie the observed cardiac conduction defects in *Xirp1* ^*−/−*^ mice.[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"}, [30](#jah32835-bib-0030){ref-type="ref"} Biochemical experiments demonstrated that Xirp1 is required for the surface expression of I~TO~ and I~K~ channel complexes. Xirp1 directly interacts with the KChIP2 subunit of I~TO~ channel complex[27](#jah32835-bib-0027){ref-type="ref"} and the actin‐binding protein, filamin.[27](#jah32835-bib-0027){ref-type="ref"}, [32](#jah32835-bib-0032){ref-type="ref"}, [33](#jah32835-bib-0033){ref-type="ref"} Both KChIP2 and filamin are essential to maintain I~TO~ current density.[34](#jah32835-bib-0034){ref-type="ref"}, [35](#jah32835-bib-0035){ref-type="ref"} In addition, Xirp1 was shown to directly interact with the actin‐binding protein, cortactin, through which Xirp1 may regulate the level of ICD‐localized cortactin and then the surface expression of I~K~ channels.[36](#jah32835-bib-0036){ref-type="ref"}, [37](#jah32835-bib-0037){ref-type="ref"}

No direct evidence has been provided to support a role for Xirp2 in cardiac electrophysiology. During the first 2 postnatal weeks in the mouse, Xirp2 is rapidly upregulated and localized to the forming ICDs where it recruits other ICD proteins, including Xirp1.[38](#jah32835-bib-0038){ref-type="ref"} Furthermore, similar to XIRP1, XIRP2 is an actin‐binding and ‐bundling protein that interacts with actin filaments through highly conserved Xin repeats.[32](#jah32835-bib-0032){ref-type="ref"}, [39](#jah32835-bib-0039){ref-type="ref"} Because actin cytoskeleton is important for channel trafficking and surface localization,[27](#jah32835-bib-0027){ref-type="ref"}, [35](#jah32835-bib-0035){ref-type="ref"}, [37](#jah32835-bib-0037){ref-type="ref"} both XIRP1 and XIRP2 may also regulate cardiac ion channel function by modulating the actin cytoskeleton. Intriguingly, *XIRP1* and *XIRP2* are located in highly conserved syntenies with sodium‐channel gene clusters on chromosome loci 3p22.2 and 2q24.3, respectively.[20](#jah32835-bib-0020){ref-type="ref"} It has been implicated that genes within highly conserved syntenies may be functionally related.[40](#jah32835-bib-0040){ref-type="ref"} The *XIRP1*‐containing locus also harbors the *SCN5A* and *SCN10A* genes that encode cardiac sodium channels and are known to be associated with BrS, long QT syndrome, and SUNDS.[14](#jah32835-bib-0014){ref-type="ref"}, [19](#jah32835-bib-0019){ref-type="ref"} On the other hand, *XIRP2*‐containing locus has not been linked to cardiac arrhythmia, but deletion of chromosome band 2q24 has been associated with congenital heart defects.[41](#jah32835-bib-0041){ref-type="ref"}

We hypothesized that *XIRP* variants may contribute to the pathogenesis of human cardiac arrhythmia disorders. In this study, genetic screens for 134 sporadic SUNDS cases and for 22 BrS patients were aimed to determine whether variants of *XIRP* are present and responsible for a proportion of SUNDS. Among a total of 20 rare variants identified, a nonsense (Q2875\*) variant and a frameshift (T2238QfsX7) variant have been found in the *XIRP2* gene from SUNDS and BrS cases, respectively. These variants, causing premature termination, might induce the nonsense‐mediated mRNA decay pathway[42](#jah32835-bib-0042){ref-type="ref"}, [43](#jah32835-bib-0043){ref-type="ref"}, [44](#jah32835-bib-0044){ref-type="ref"} and result in reduced amount of XIRP2 in the heart. Using mouse knockout models and biochemical approaches, we provided further evidence that Xirp2 is essential for normal cardiac conduction.

Materials and Methods {#jah32835-sec-0009}
=====================

The data, analytical methods, and study materials will be made available to other researchers upon request for purposes of reproducing the results or replicating the procedure.

Study Population {#jah32835-sec-0010}
----------------

In this study, 134 sporadic SUNDS cases from 2004 to 2015 were diagnosed and collected by the Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat‐sen University (China National Forensic Autopsy Center). Inclusion criteria for SUNDS were as follows[6](#jah32835-bib-0006){ref-type="ref"}, [7](#jah32835-bib-0007){ref-type="ref"}: (1) a Chinese Han aged ≥15 years; (2) apparently healthy without any previously significant disease; (3) before experiencing a sudden unexpected death at night during sleep with symptoms of moaning, apnea, and abrupt tic of limbs; and (4) negative postmortem findings of the standard forensic autopsy, histopathology examination, toxicological analysis, and death‐scene investigation.

Twenty‐two BrS cases from 2007 to 2015 were collected from the First Affiliated Hospital of Sun Yat‐sen University to screen *XIRP* variants. Inclusion criteria for BrS patients were[7](#jah32835-bib-0007){ref-type="ref"}: (1) a basal ECG showing a BrS type I pattern; (2) at least 1 clinical criterion (documented family history of BrS or sudden cardiac death, and/or symptoms secondary to arrhythmia); and (3) no structural heart disease.

All of these SUNDS and BrS cases were previously screened for deleterious rare variants in 39 primary arrhythmia‐associated genes,[7](#jah32835-bib-0007){ref-type="ref"} including *SCN5A*,*MOG1*,*GPD1L*,*SCN10A*,*CACNB2*,*SCN1B‐4B*,*KCNE3*,*KCND3*,*KCNJ8*,*KCNQ1*,*KCNH2*,*ANK2*,*KCNE1*,*KCNE2*,*KCNJ2*,*CACNA1C*,*CAV3*,*AKAP9*,*SNTA1*,*GJA1*,*KCNJ5*,*RYR2*,*CASQ2*,*ANK2*,*TRDN*,*PRKAG2*,*HCN4*,*KCNA5*,*NPPA*,*NUP155*,*GJA5*,*ABCC9*,*GATA4*,*GATA5*,*GATA6*, and *KCNE1L*. A control population of 649 age‐ and ethnic‐matched unrelated healthy Chinese Han (1298 alleles) were provided by the China National GeneBank, BGI‐Shenzhen. None of the control subjects had a history of syncope or cardiovascular disease.

Informed consent was obtained from BrS patients and legal representatives of SUNDS victims. Principles outlined in the Declaration of Helsinki were followed. The project was approved for human research by the ethics committee of Sun Yat‐sen University.

Genetic Variants Analysis {#jah32835-sec-0011}
-------------------------

Genomic DNA was extracted from blood samples as reported previously.[6](#jah32835-bib-0006){ref-type="ref"}, [7](#jah32835-bib-0007){ref-type="ref"}, [14](#jah32835-bib-0014){ref-type="ref"}, [15](#jah32835-bib-0015){ref-type="ref"}, [16](#jah32835-bib-0016){ref-type="ref"}, [17](#jah32835-bib-0017){ref-type="ref"}, [18](#jah32835-bib-0018){ref-type="ref"}, [19](#jah32835-bib-0019){ref-type="ref"} All coding regions and exon‐intron boundaries for *XIRP1* and *XIRP2* (GenBank [NM_194293.2](NM_194293.2) and [NM_152381.5](NM_152381.5), respectively) were polymerase chain reaction amplified using designed primers (Table [S1](#jah32835-sup-0001){ref-type="supplementary-material"}). Polymerase chain reaction products were directly sequenced on an ABI 3730XL Automated DNA Analyzer (Applied Biosystems, Foster City, CA). Sequencing data were compared with the corresponding reference sequence using SeqManTMII expert sequence analysis software (DNASTAR, Inc, Madison, WI). All suspicious variants were confirmed using the opposite primer. A standard nomenclature for the description of sequence variants has been agreed upon on <http://varnomen.hgvs.org/>.

Genomic data of East Asian (EAS) from 1000 Genomes Project Phase 3 (<http://browser.1000genomes.org/>, all 5008 alleles, EAS 1008 alleles, Southern Han Chinese 210 alleles, Han Chinese in Beijing 206 alleles), Exome Aggregation Consortium (ExAC; <http://exac.broadinstitute.org/>, all 121 412 alleles, EAS 8654 alleles), and Genome Aggregation Database (gnomAD; <http://gnomad.broadinstitute.org/>, all 277 264 alleles, EAS 18 870 alleles) were accessed to compare allele frequency. Variants absent from the local database, ExAC, gnomAD, and database of single‐nucleotide polymorphism (<http://www.ncbi.nlm.nih.gov/snp>) were defined as novel. Variants identified with a minor allele frequency (MAF) less than 0.01 were termed as rare. If the MAF was higher than 0.01, variants were regarded as common. Online in silico prediction tools SIFT (<http://sift.jcvi.org/>), Polyphen‐2 (<http://genetics.bwh.harvard.edu/pph2/>), and CONDEL (<http://bg.upf.edu/fannsdb/>) were used to evaluate deleteriousness of missense variants. Candidate variants were filtered based on the following: MAF, type of variant, in silico prediction (SIFT, Polyphen‐2, and CONDEL), and related published literature. The "radical" variants, including nonsense and frameshift, were treated as candidate variants unless identified as common variants. Filtered variants were predicted to be deleterious if all the 3 software made concordant predictions. All the filtered variants were then classified to 5 categories based on their clinical significance (pathogenic, likely pathogenic, variant of uncertain significance, likely benign, and benign) according the American College of Medical Genetics Guidelines Revisions.[45](#jah32835-bib-0045){ref-type="ref"}

Mouse Models {#jah32835-sec-0012}
------------

All animal procedures were approved and conducted in accord with institutional guidelines. *Xirp2* ^*−/−*^ mice were reported on previously.[31](#jah32835-bib-0031){ref-type="ref"} Mice expressing β‐galactosidase under the control of endogenous *Xirp2* regulatory elements were generated by crossing mice bearing *Xirp2* ^*tm1a(KOMP)Wtsi*^ allele (obtained from UC Davis KOMP Repository) with mice expressing Cre recombinase in the germline (EK‐Cre, a kind gift from Dr Baoli Yang, University of Iowa), which resulted in *Xirp2* ^*+/lacZ‐tm2*^ mice expressing *LacZ* under the control of the endogenous *Xirp2* promoter.

Optical Mapping {#jah32835-sec-0013}
---------------

Optical mapping was carried out as described previously.[29](#jah32835-bib-0029){ref-type="ref"} The cannulated, perfused heart was further stained with di‐4‐ANEPPS as a voltage‐sensitive dye. The stained heart was paced at the basal portion of the right ventricle from a stimulator as described.[29](#jah32835-bib-0029){ref-type="ref"} Fluorescence emission from the paced heart was collected and processed to form an image detecting a 5×5 mm area of the epicardium. Spatial and temporal filtering were utilized in data postprocessing. Isochronal maps of activation spread (activation map) and conduction velocity measurements were derived using Cardioplex software (RedShirtImaging).

ECG Recordings {#jah32835-sec-0014}
--------------

ECG recordings of age‐matched *Xirp2* ^*+/+*^ and *Xirp2* ^*−/−*^ littermates were performed under anesthesia with sodium pentobarbital (50 mg/kg, intraperitoneally) as described previously.[46](#jah32835-bib-0046){ref-type="ref"} ECG signals were recorded with an ECG amplifier and recorder (RS3400; Gould Instruments, Basingstoke, UK). ECG parameters, such as P wave, QRS, QT, and R‐R intervals, were calculated from ECG tracings as described previously.[28](#jah32835-bib-0028){ref-type="ref"} Bazett\'s formula was used to calculate corrected QT interval.

Electrophysiological Studies of Isolated Ventricular Myocytes {#jah32835-sec-0015}
-------------------------------------------------------------

Ventricular myocytes were enzymatically isolated from age‐matched *Xirp2* ^+/+^ and *Xirp2* ^−/−^ mouse hearts as described previously.[27](#jah32835-bib-0027){ref-type="ref"} The whole‐cell patch‐clamp was performed in ventricular myocytes to acquire action potential (AP) characteristics and ionic current properties, as described in detail.[27](#jah32835-bib-0027){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"} The ionic currents studied included the inward Na^+^ current (I~Na~), the transient outward K^+^ current (I~TO~), the delayed rectifier outward K^+^ current (I~K~), and the Ba^2+^‐sensitive inward rectifier K^+^ current (I~K1~).

Histology and Immunofluorescence Microscopy {#jah32835-sec-0016}
-------------------------------------------

Whole‐heart X‐gal and immunofluorescence stainings were carried out as described previously.[31](#jah32835-bib-0031){ref-type="ref"}, [47](#jah32835-bib-0047){ref-type="ref"} Rabbit anti‐hyperpolarization‐activated cyclic nucleotide‐gated K^+^ channel 4 (HCN4; AB5808; Millipore, Burlington, MA) or rabbit anti‐connexin 40 (Cx40; AB1726; Millipore) was used as the primary antibody to facilitate the identification of atrioventricular node and His‐bundle/bundle branches.[48](#jah32835-bib-0048){ref-type="ref"} After staining with rhodamine‐conjugated secondary antibody, the section was stained with Alexa Fluor 488--conjugated wheat germ agglutinin (WGA488). Sections were imaged with a Leica TCS SPE confocal microscope (Leica Microsystems, Wetzlar, Germany). Under the same conditions, fluorescence intensity and particle size were estimated and compared from 5 confocal images each of *Xirp2* ^+/+^ and *Xirp2* ^−/−^ heart sections with ImageJ (NIH, Bethesda, MD), as described previously.[38](#jah32835-bib-0038){ref-type="ref"} Histological staining for acetylcholine esterase (AChE) activity was performed as described previously[49](#jah32835-bib-0049){ref-type="ref"} on the adjacent section to that used in immunofluorescence for identifying the cardiac conduction system.

Co‐Immunoprecipitation and Western Blot {#jah32835-sec-0017}
---------------------------------------

Hearts harvested from 2 adult wild‐type mice were pulverized in liquid nitrogen and incubated in extraction buffer containing 20 mmol/L of HEPES pH7.2, 120 mmol/L of NaCl, 10 mmol/L of MgCl~2~, 1 mmol/L of DTT, 1× protease inhibitor cocktail without EDTA (Sigma‐Aldrich, St. Louis, MO), 5% glycerol, and 0.5% Triton X‐100 at 4°C for 15 minutes. Total lysate was clarified by centrifugation at 10 000*g* for 10 minutes. Co‐immunoprecipitation (Co‐IP) was carried out by incubating Dynabeads protein G cross‐linked rabbit anti‐Kv1.5 (AB9786; Chemicon International, Billerica, MA), rabbit anti‐Nav1.5 (ASC005; Alomone Labs, Jerusalem, Israel), mouse anti‐Kv4.2 (NeuroMab, Davis, CA), rabbit anti‐GAPDH (Cell Signaling Technology, Danvers, MA), U1697 (rabbit antimouse Xirp1 peptide, aa\# 564--583 of mXinα),[28](#jah32835-bib-0028){ref-type="ref"} U1040 (rabbit antimouse Xirp2 C‐terminus, aa\# 3255--3278 of mXinβ),[31](#jah32835-bib-0031){ref-type="ref"} or U1013 (rabbit antimouse Xirp1, aa\# 1--532 of mXinα)[28](#jah32835-bib-0028){ref-type="ref"}, [31](#jah32835-bib-0031){ref-type="ref"} with clarified total lysate overnight. After washing, immunoprecipitates were boiled in gel sample buffer and analyzed by western blot as previously described.[31](#jah32835-bib-0031){ref-type="ref"}

Statistical Analysis {#jah32835-sec-0018}
--------------------

Genotype frequencies were calculated by the genotype counting method. Data from electrophysiological studies are presented as median±interquartile range or mean±SEM. Statistical analysis, including ANOVA, Student *t* test, or Mann--Whitney *U* rank‐sum test, was used to test the difference between 2 groups. A *P* value \<0.05 was considered statistically significant.

Results {#jah32835-sec-0019}
=======

Demographics of Study Population {#jah32835-sec-0020}
--------------------------------

Death age of 134 SUNDS cases (3 females) was 30.8±7.6 years (range, 15--55). All these apparently healthy SUNDS victims without family history of sudden death were sporadic and lacked clinical records. There were no significant pathological alterations identified to elucidate these sudden deaths after comprehensive forensic autopsy examination.

All but 4 (father and son from 1 family, 2 brothers from another family) of the 22 BrS patients (2 females) were unrelated. Age at the time of diagnosis was 42.2±10.8 years (range, 20--60). A total of 18 of 22 BrS cases had suffered previous syncope and seizures. A total of 9 of 22 BrS had a family history of sudden unexpected death or BrS. A total of 8 of 22 BrS cases had suffered an episode of spontaneous ventricular fibrillation and had a cardioverter defibrillator implanted (Figure [1](#jah32835-fig-0001){ref-type="fig"} shows a representative BrS ECG).

![A representative Brugada syndrome (BrS) ECG. This typical BrS ECG (ST‐segment elevation among the right precordial leads V1 and V2) was recorded from a 56‐year‐old male who had recurrent episodes of syncope and ventricular fibrillation with implantable cardioverter defibrillator treatment. This patient tested negative for structural heart disease by magnetic resonance imaging and echocardiograph examination.](JAH3-7-e006320-g001){#jah32835-fig-0001}

Rare Variants in Chinese Sporadic SUNDS Victims and BrS Patients {#jah32835-sec-0021}
----------------------------------------------------------------

Sixteen rare variants in *XIRP* genes were identified in 134 (11.2%) sporadic SUNDS cases (Table [1](#jah32835-tbl-0001){ref-type="table-wrap"}). Five of the variants (T4A, E75K, Q856R, A930V, and T1830M) were located in the *XIRP1* coding region, and the other 11 variants (V51A, S52L, E215K, A288S, E737K, I1899N, V2121I, D2177N, N2233S, Q2875\*, and R3223H) were found in the *XIRP2* coding region. One variant was a nonsense variant (Q2875\*) located in exon 9 of the *XIRP2* gene with substitution c.8623C\>T whereas the remaining 15 were missense variants (Table [1](#jah32835-tbl-0001){ref-type="table-wrap"}). Among these 16 rare variants, 1 was a novel variant (E215K) located in exon 4 of the *XIRP2* gene in SUNDS case E89. Of these 16 rare variants, 6 were in silico predicted as deleterious (A930V, E215K, E737K, I1899N, Q2875\*, and R3223H). Interestingly, rare variant A930V of XIRP1 and deleterious common variant V1743I of XIRP2 (Table [S2](#jah32835-sup-0001){ref-type="supplementary-material"}, found in SUNDS with MAF=0.005 in 105 Southern Han Chinese from 1000 Genomes Project Phase 3 and with MAF more than 0.01 in EAS from ExAC, 1000 Genomes Project Phase 3, and gnomAD) are located very close to each other on the consensus sequence (Table [S3](#jah32835-sup-0001){ref-type="supplementary-material"}) of the highly conserved regions immediately after the Xin repeats of XIRP1 and XIRP2,[26](#jah32835-bib-0026){ref-type="ref"} which possess 2 previously identified α‐actinin‐binding regions[50](#jah32835-bib-0050){ref-type="ref"} (Table [S4](#jah32835-sup-0001){ref-type="supplementary-material"}). The variant, R3223H, is located within the consensus sequences for nuclear localization signal (NLS) of XIRP2, whereas nonsense variant Q2875\* should result in a lack of this NLS (Figure [2](#jah32835-fig-0002){ref-type="fig"}). The majority of the remaining missense variants are located within the highly conserved XIRP isoform‐specific regions at the N‐terminus and at the sequences immediately downstream of the Xin repeats,[26](#jah32835-bib-0026){ref-type="ref"} where limited functional information is known (Table [S4](#jah32835-sup-0001){ref-type="supplementary-material"}).

###### 

Rare Variants of *XIRP* Genes in SUNDS Cases

  Case    Gene        Age, y   Nucleotide Change   Amino Acid Change   Type of Variant   dbSNP         Chinese Han   EAS        Prediction In Silico[a](#jah32835-note-0006){ref-type="fn"}   ACMG Classification[b](#jah32835-note-0007){ref-type="fn"}                                               
  ------- ----------- -------- ------------------- ------------------- ----------------- ------------- ------------- ---------- ------------------------------------------------------------- ------------------------------------------------------------ ---------- ------- ---------- ------------- -------------------
  E145    *XIRP1*     33       c.10A\>G            p.T4A               missense          rs780225117   1298          0          416                                                           0                                                            0.00012    ···     0.000273   neutral       VUS
  E144    *XIRP1*     20       c.223G\>A           p.E75K              missense          rs749373055   1298          0          416                                                           0                                                            0.00127    ···     0.00159    neutral       VUS
  E7      *XIRP1*     36       c.2567A\>G          p.Q856R             missense          rs751104961   1298          0          416                                                           0                                                            0.00047    ···     0.000371   neutral       VUS
  E128    *XIRP1*     24       c.2789C\>T          p.A930V             missense          ···           1298          0          416                                                           0                                                            ···        ···     0.000116   deleterious   VUS
  E97     *XIRP1*     30       c.5489C\>T          p.T1830M            missense          rs142746395   1298          0.005393   416                                                           0.01442308                                                   0.00451    0.007   0.00482    neutral       VUS
  E101    *XIRP2*     31       c.152T\>C           p.V51A              missense          rs775164919   1298          0.00077    416                                                           0                                                            0          ···     0.000266   neutral       VUS
          *AKAP9*              c.11135G\>A         p.R3712Q            missense          rs186148498   1298          0          416                                                           0.00480769                                                   0.00832    0.006   0.00885    deleterious   VUS
  E113    *XIRP2*     19       c.155C\>T           p.S52L              missense          rs567637067   1298          0          416                                                           0                                                            0.00152    0.003   0.00123    neutral       VUS
  E89     *XIRP2*     37       c.643G\>A           p.E215K             missense          ···           1298          0          416                                                           0                                                            ···        ···     ···        deleterious   VUS
  E136    *XIRP2*     40       c.862G\>T           p.A288S             missense          rs552549925   1298          0.00077    416                                                           0                                                            0.00349    0.001   0.00377    neutral       VUS
          *KCNH2*              c.3110A\>T          p.D1037V            missense          ···           1298          0          416                                                           0                                                            ···        ···     ···        deleterious   VUS
  ZS032   *XIRP2*     35       c.2209G\>A          p.E737K             missense          rs201995517   1298          0          416                                                           0                                                            0.00035    ···     0.000106   deleterious   VUS
          *CACNA1C*            c.4393T\>C          p.F1465L            missense          ···           1298          0          416                                                           0                                                            ···        ···     ···        deleterious   VUS
  ZS120   *XIRP2*     42       c.5696T\>A          p.I1899N            missense          rs748428961   1298          0          416                                                           0                                                            0.00082    ···     0.000582   deleterious   VUS
  ZS146   *XIRP2*     20       c.6361G\>A          p.V2121I            missense          rs181373166   1298          0.00154    416                                                           0.00721                                                      0.003385   0.006   0.002875   neutral       VUS
  E122    *XIRP2*     30       c.6529G\>A          p.D2177N            missense          rs113038974   1298          0          416                                                           0                                                            0.0007     ···     0.000748   neutral       VUS
  E135    *XIRP2*     33       c.6698A\>G          p.N2233S            missense          rs778173531   1298          0.00077    416                                                           0                                                            0          ···     0          neutral       VUS
  E78     *XIRP2*     38       c.8623C\>T          p.Q2875\*           nonsense          rs201881932   1298          0.00077    416                                                           0.00240385                                                   0.00093    0.001   0.00101    deleterious   Likely pathogenic
  E148    *XIRP2*     27       c.9668G\>A          p.R3223H            missense          rs778569774   1298          0          416                                                           0                                                            0          ···     0          deleterious   VUS

ACMG indicates American College of Medical Genetics and Genomics; CHB, Han Chinese in Beijing; CHS, Southern Han Chinese; EAS, East Asian; MAF, minor allele frequency; SUNDS, sudden unexplained nocturnal death syndrome; VUS, variant of uncertain significance.

Evaluated by 3 in silico tools (SIFT, Polyphen‐2, and CONDEL) and harboring "radical" variants or not.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

![Schematic diagrams depict relative positions of XIRP rare variants to their respective domains/regions. The variant positions identified from sudden unexplained nocturnal death syndrome (black font) and Brugada syndrome (red font) cases are shown on the top diagram, whereas the known domains and unknown, but conserved, regions are shown in the bottom diagram of each XIRP protein. The Xin‐repeat regions (pink) were identified from human XIRP and mouse XIRP, and experimentally verified as actin‐binding and ‐bundling domains from XIRP [39](#jah32835-bib-0039){ref-type="ref"} and mouse small Xirp1‐S (mXinα).[32](#jah32835-bib-0032){ref-type="ref"} Within the Xin repeats, the overlapped β‐catenin‐binding domain (β‐catBD, light green) was experimentally defined in Xirp1‐S.[32](#jah32835-bib-0032){ref-type="ref"} The β‐catBD is highly conserved among all Xin‐containing proteins from all animal species.[26](#jah32835-bib-0026){ref-type="ref"} Both Ena/VASP‐binding domain (E/V BD, light purple) and filamin c‐binding region (blue) were experimentally identified from human XIRP1.[33](#jah32835-bib-0033){ref-type="ref"} However, these similar sequences were not found in XIRP2. Based on sequence similarity, DNA‐binding domain (DBD) and proline‐rich (PR) region, including SH3‐binding motifs of PR‐1, PR‐2, and PR‐3, were found in both XIRP proteins.[26](#jah32835-bib-0026){ref-type="ref"} On the other hand, nuclear export signal (NES), nuclear localization signal (NLS), and ATP_GTP_A loop were only found in XIRP2.[26](#jah32835-bib-0026){ref-type="ref"} Conserved sequences immediately after the Xin‐repeat region (aa\# 739--1076 of XIRP1 and aa\# 1536--1933 of XIRP2) were slightly divergent between XIRP1 and XIRP2, but each was highly conserved across all species examined.[26](#jah32835-bib-0026){ref-type="ref"}](JAH3-7-e006320-g002){#jah32835-fig-0002}

There were also 4 rare variants (Table [2](#jah32835-tbl-0002){ref-type="table-wrap"}) identified in 22 (18.2%) BrS cases, including 3 missense variants (V118M in *XIRP1*; R1715H and L2718P in *XIRP2*), and 1 frameshift variant (c.6712‐6713delAC \[p.T2238QfsX7\] in *XIRP2*). Among these rare variants, L2718P was novel and located in exon 9 of the *XIRP2* gene. V118M in *XIRP1* and T2238QfsX7 in *XIRP2* were predicted as deleterious variants. The enrichment of deleterious rare variants in *XIRP1* and *XIRP2* in both SUNDS and BrS cases suggests that both XIRP proteins may be important determinants in normal cardiac rhythms.

###### 

Rare Variants of *XIRP* Genes in BrS Patients

  Case    Gene      Age, y   Nucleotide Change   Amino Acid Change   Type of Variant   dbSNP         Chinese Han   EAS        Prediction In Silico[a](#jah32835-note-0009){ref-type="fn"}   ACMG Classification[b](#jah32835-note-0010){ref-type="fn"}                                                
  ------- --------- -------- ------------------- ------------------- ----------------- ------------- ------------- ---------- ------------------------------------------------------------- ------------------------------------------------------------ ---------- ------- ----------- ------------- -------------------
  ZS106   *XIRP1*   53       c.352G\>A           p.V118M             missense          rs115823205   1298          0.002311   416                                                           0                                                            0          0       0.0000530   deleterious   VUS
          *SCN5A*            c.5676delC          p.T1893PfsX29       frameshift        ···           1298          0          416                                                           0                                                            ···        ···     ···         deleterious   Pathogenic
          *SCN5A*            c.5692C\>T          p.R1898C            missense          rs373118001   1298          0          416                                                           0                                                            0.000116   0.002   0.0000530   deleterious   VUS
  ZS109   *XIRP2*   55       c.5144G\>A          p.R1715H            missense          rs552071889   1298          0.00077    416                                                           0                                                            0.000233   0       0.000266    neutral       VUS
  ZS116   *XIRP2*   42       c.6712_6713delAC    p.T2238QfsX7        frameshift        rs749764225   1298          0          416                                                           0                                                            0.000117   ···     0.000117    deleterious   Likely pathogenic
  IPS     *XIRP2*   57       c.8153T\>C          p.L2718P            missense          ···           1298          0          416                                                           0                                                            ···        ···     ···         neutral       VUS

BrS, Brugada syndrome; CHB, Han Chinese in Beijing; CHS, Southern Han Chinese; EAS, East Asian; MAF, minor allele frequency; VUS, variant of uncertain significance.

Evaluated by 3 in silico tools (SIFT, Polyphen‐2, and CONDEL) and harboring "radical" variants or not.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

According to our previous molecular autopsy investigation, all of the SUNDS (except for SUNDS cases E101, E136, and ZS032 \[Table [1](#jah32835-tbl-0001){ref-type="table-wrap"}\]) and BrS cases (except for BrS case ZS106 \[Table [2](#jah32835-tbl-0002){ref-type="table-wrap"}\]) with *XIRP* rare variants were negative for deleterious rare variants in 39 genes associated with lethal arrhythmias.[7](#jah32835-bib-0007){ref-type="ref"}

Common Variants Identified in Chinese Sporadic SUNDS and BrS Cases {#jah32835-sec-0022}
------------------------------------------------------------------

Twenty‐nine nonsynonymous common variants were identified in SUNDS cases (Table [S2](#jah32835-sup-0001){ref-type="supplementary-material"}), including 7 in *XIRP1* and 22 in *XIRP2*. All of these 29 variants were identified in EAS and Chinese Han, and 24 of the 29 were identified in BrS cases. The remaining 5 variants (rs75802875, rs181539061, rs77219745, rs3749002, and rs143084183) were not detected in the BrS cases (Table [S2](#jah32835-sup-0001){ref-type="supplementary-material"}). Characters of XIRP common variants in SUNDS and BrS cases are shown in Table [S2](#jah32835-sup-0001){ref-type="supplementary-material"}.

Xirp2 Is Required for Formation of Infranodal Ventricular Conduction System {#jah32835-sec-0023}
---------------------------------------------------------------------------

Supporting a causative role of *XIRP1* rare variants in SUNDS and BrS, our previous studies showed that mouse Xirp1 is important for maintenance of ICD integrity.[25](#jah32835-bib-0025){ref-type="ref"}, [27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"} Through its interactions with β‐catenin,[32](#jah32835-bib-0032){ref-type="ref"} p120‐catenin,[36](#jah32835-bib-0036){ref-type="ref"} KChIP2,[27](#jah32835-bib-0027){ref-type="ref"} filamin,[27](#jah32835-bib-0027){ref-type="ref"}, [32](#jah32835-bib-0032){ref-type="ref"} and cortactin,[36](#jah32835-bib-0036){ref-type="ref"} Xirp1 influences surface expression of channels responsible for the transient outward K^+^ current (I~TO~) and delayed K^+^ rectifier current (I~K~).[25](#jah32835-bib-0025){ref-type="ref"}, [27](#jah32835-bib-0027){ref-type="ref"} Loss of Xirp1 in mice led to abnormal AP and conduction defects.[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"}, [30](#jah32835-bib-0030){ref-type="ref"} Although complete loss of Xirp2 resulted in postnatal lethality,[25](#jah32835-bib-0025){ref-type="ref"}, [31](#jah32835-bib-0031){ref-type="ref"} a small number of *Xirp2* ^−/−^ mice survived to postnatal day (P) 20. Studies with these *Xirp2* ^−/−^ mice also revealed evidence to suggest a causative role of some *XIRP2* rare variants, such as nonsense Q2875\* and frameshift T2238QfsX7 variants expressing little or no XIRP2, in SUNDS and BrS.

### (i) *Xirp2* ^−/−^ Mouse Hearts Exhibited Slow Conduction Velocity, Prolonged QT Interval, and Atrioventricular Conduction Block {#jah32835-sec-0024}

Previous echocardiographic comparisons on wild‐type and *Xirp2* ^−/−^ mice showed a diastolic dysfunction associated with these *Xirp2* ^−/−^ mice.[31](#jah32835-bib-0031){ref-type="ref"} Using an optical mapping technique, we further detected a 45% reduction in conduction velocity in *Xirp2* ^−/−^ left ventricles compared with *Xirp2* ^+/+^ controls (Figure [3](#jah32835-fig-0003){ref-type="fig"}B). As can be seen in Figure [3](#jah32835-fig-0003){ref-type="fig"}A, when paced at the base of the right ventricle, activation in *Xirp2* ^+/+^ heart spread immediately and smoothly throughout the left ventricle, whereas it took more time in the *Xirp2* ^−/−^ hearts to reach the same activated area. These results indicate a conduction defect associated with *Xirp2* ^−/−^ ventricles.

![Optical mapping on the front surface of left ventricles from *Xirp2* ^*+/+*^ and *Xirp2* ^−*/*−^ hearts. A, Activation maps of ventricles induced by electrical pacing. Left panel is the heatmap from 1 *Xirp2* ^*+/+*^ ventricle, whereas middle and right panels are maps from 2 *Xirp2* ^−*/*−^ ventricles. The scale bar of the heatmap represents the time required for action potential (AP) propagating from the site of electric stimulation to a given ventricle position, which ranges from the shortest time (blue color, 0 ms) to the longest time (red color, 16 ms). The heart diagram underneath *Xirp2* ^+/+^ map depicts the site of electrical stimulation (\*) and the activation direction (oblique arrow). Note that *Xirp2* ^−/−^ ventricles exhibited slow AP propagation. B, Calculated conduction velocity of *Xirp2* ^*+/+*^ (black boxplots) and *Xirp2* ^−*/*−^ (gray boxplots) left ventricles: on each box, the central mark is the median, the edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data points. \*\**P*\<0.01, significant differences between 2 groups. n, number of mice tested (5 mice each group). WT indicates wild type.](JAH3-7-e006320-g003){#jah32835-fig-0003}

To further show a conduction defect in the *Xirp2* ^−/−^ hearts, we performed ECG recordings on age‐matched *Xirp2* ^+/+^ and *Xirp2* ^−/−^ mice. Each of a representative ECG trace is shown in Figure [4](#jah32835-fig-0004){ref-type="fig"}A and [4](#jah32835-fig-0004){ref-type="fig"}B for a *Xirp2* ^+/+^ and a *Xirp2* ^−/−^ mouse younger than P18. Table [3](#jah32835-tbl-0003){ref-type="table-wrap"} summarizes the ECG parameters calculated from tracings of 12 *Xirp2* ^+/+^ and 8 *Xirp2* ^−/−^ mice at P14 to P17. Significantly prolonged PR interval (representing the period of atrioventricular (A‐V) conduction) and prolonged QT and QTc intervals (representing the period between depolarization and repolarization of ventricle), but no changes in P wave and QRS interval, were detected in *Xirp2* ^−/−^ mice. These results further suggest a defect in the infranodal ventricular conduction system in *Xirp2* ^−/−^ mice. Interestingly, all of the P18 *Xirp2* ^*−*/−^ mice examined had a severe A‐V conduction block. Figure [4](#jah32835-fig-0004){ref-type="fig"}C shows 2 examples of such an A‐V conduction block with many P waves (indicated by the arrows) followed by no QRS wave.

![ECG tracings from age‐matched *Xirp2* ^*+/+*^ and *Xirp2* ^−*/*−^ mice. A, ECG trace of a representative *Xirp2* ^*+/+*^ mouse at P14 to P17. The durations for P wave as well as PR,QRS,QT, and R‐R intervals are defined in this trace. B, ECG trace of a representative *Xirp2* ^−*/*−^ mice at P14 to P17. C, Atrioventricular conduction (A‐V) blocks detected in all tested *Xirp2* ^−*/*−^ mice at P18. Two representative ECG traces showed such A‐V block with many P waves followed by missing QRS (indicated by arrows).](JAH3-7-e006320-g004){#jah32835-fig-0004}

###### 

Conduction Parameters (14‐ to 17‐day‐old) and Incidence of A‐V block (18‐day‐old) Determined by Surface ECG Recording From *Xirp2* ^+/+^ and *Xirp2* ^−/−^ Mice

                                         *Xirp2* ^+/+^   *Xirp2* ^−/−^
  -------------------------------------- --------------- -------------------------------------------------
  No. of 14‐ to 17‐day‐old mice tested   12              8
  P wave, ms                             11.8±0.3        12.6±0.9
  PR interval, ms                        39.2±0.3        45.9±3.5[a](#jah32835-note-0012){ref-type="fn"}
  QRS interval, ms                       13.5±0.5        13.5±1.2
  QT interval, ms                        24.8±0.9        31.1±1.5[a](#jah32835-note-0012){ref-type="fn"}
  QTc interval, ms                       17.4±0.6        21.2±0.7[b](#jah32835-note-0013){ref-type="fn"}
  R‐R interval, ms                       217.5±10.0      223.0±24.9
  Number of 18‐day‐old mice tested       7               7
  Incidence of A‐V conduction block      0%              100%[b](#jah32835-note-0013){ref-type="fn"}

Values are presented as mean±SEM. A‐V indicates atrioventricular conduction; QTc, corrected QT interval.

*P*\<0.05.

*P*\<0.01 significant difference between *Xirp2* ^+/+^ and *Xirp2* ^−/−^ mice.

### (ii) Xirp2 Expressed in Atria and Ventricular Conduction System and Complete Loss of Xirp2 Resulted in Underdevelopment of His‐Bundle and Purkinje Fibers {#jah32835-sec-0025}

The A‐V block phenotype suggested an involvement of Xirp2 in the ventricular conduction system. Therefore, we first sought to better define the expression profile of *Xirp2* in the mouse heart. We generated mice expressing β‐galactosidase under the control of endogenous *Xirp2* regulatory elements from an *LacZ* gene inserted into the *Xirp2* locus (*Xirp2* ^*lacZ−tm2*^; Figure [5](#jah32835-fig-0005){ref-type="fig"}A). In adult heterozygous *Xirp2* ^*lacZ−tm2/+*^ hearts, the β‐galactosidase signal was diffused and homogeneous in the atria, but heterogeneous in the ventricles (Figure [5](#jah32835-fig-0005){ref-type="fig"}B, panel b), whereas no signal was detected in *Xirp2* ^+/+^ hearts (Figure [5](#jah32835-fig-0005){ref-type="fig"}B, panel a). En face view of the right ventricular endocardial surface showed that *LacZ* was widely expressed, but the strongest signal was associated with Purkinje fiber‐like structures, which are similar to that in β‐galactosidase‐stained hearts from CCS‐*lacZ* transgenic mice[51](#jah32835-bib-0051){ref-type="ref"} (Figure [5](#jah32835-fig-0005){ref-type="fig"}B, panel c).

![β*‐galactosidase* (β*‐Gal*) expression under the endogenous *Xirp2* promoter in *Xirp2* ^*+/*lacZ‐tm2^ mice. A, Schematic representations of endogenous *Xirp2* locus, targeted locus (*Xirp2* ^*tm1a(KOMP)Wtsi*^) and *Xirp2* ^*lacZ‐tm2*^ locus. After verification of homologous recombination and germline transmission, the resulting mice carrying targeted locus with the replacement of endogenous exon 4 (E4) and E5 by the DNA fragment containing FRT‐*LacZ*‐Loxp‐*Neo*‐FRT‐LoxP‐*E4*‐*E5*‐LoxP from the KOPM targeting vector were bred with EK‐Cre transgenic mice to generate *Xirp2* ^*lacZ‐tm2*^ mice (with a knock‐in *LacZ* gene under the control of *Xirp2* promoter/enhancer and a disruption of *Xirp2* expression called *lacZ‐tm2* distinguished from our original *Xirp2* knockout mice). B, β‐gal stain of P20 wild‐type (*Xirp2* ^+/+^) and *Xirp2* ^*+/lacZ‐tm2*^ mouse hearts. a, Wild‐type heart serves as a negative stain control; b, heterozygous *Xirp2* ^*+/lacZ‐tm2*^ heart shows strong β‐gal in atria and weak/diffuse stain in ventricle; and c, dissected *Xirp2* ^*+/lacZ‐tm2*^ right ventricle at the endocardium view shows positive stain on what appears to be ventricular conduction system including Purkinje fibers. Bar in b=1 mm for a and b; bar in c=1 mm.](JAH3-7-e006320-g005){#jah32835-fig-0005}

The above *Xirp2* expression pattern, together with conduction defects observed in *Xirp2*‐null hearts, led us to hypothesize that Xirp2 may play an important role in the development of the ventricular conduction system. We thus performed histochemical stain for AChE activity (a marker for the ventricular conduction system[49](#jah32835-bib-0049){ref-type="ref"}) on serial sections of entire hearts prepared from *Xirp2* ^*+/+*^ and *Xirp2* ^−/−^ mice. Examples of such stains at Purkinje fiber regions are shown in Figure [6](#jah32835-fig-0006){ref-type="fig"} for comparisons. AChE activities, as detected by the brown color stains, were clearly diminished from the endocardial surface of the right ventricle of *Xirp2* ^−*/*−^ hearts (Figure [6](#jah32835-fig-0006){ref-type="fig"}), suggesting that the Purkinje fibers might not be properly developed.

![Acetylcholine esterase (AChE) stain revealing a reduction in Purkinje fibers of P18 *Xirp2* ^−/−^ heart. Serial 10‐μm sections (sectioning from frontal/ventral to dorsal) of entire hearts from *Xirp2* ^*+/+*^ and *Xirp2* ^−*/*−^ mice were histochemically stained for AChE activity (brown) to reveal the ventricular conduction system. Purkinje fibers were positively stained in representative sections of *Xirp2* ^*+/+*^ heart (a, section \#252; b, \#261; and c, \#283), whereas comparable sections of *Xirp2* ^−*/*−^ heart showed a drastically reduced in AChE activity (d, section \#129; e, \#139; and f, \#149). Bar in e=1 mm for a through f. rv, right ventricle; lv, left ventricle; ivs, interventricular septum. (c′ and f′) higher magnification of the box regions in c and f, respectively. Bar in f'=0.2 mm for c′ and f′.](JAH3-7-e006320-g006){#jah32835-fig-0006}

To further investigate the expression of HCN4 and Cx40 in the atrioventricular node and His‐bundle and bundle branches, we immunofluorescently labeled an adjacent section to that stained for AChE activity. As can be seen in Figure [7](#jah32835-fig-0007){ref-type="fig"} (panels a and e), AChE staining was not different in the atrioventricular node as identified by anti‐HCN4 staining between *Xirp2* ^+/+^ and *Xirp2* ^−/−^ hearts. Similarly, immunofluorescent intensity of HCN4 within the atrioventricular node was undistinguished (Figure [7](#jah32835-fig-0007){ref-type="fig"}). Cx40 is a major gap junction protein of the His‐bundle and bundle branches, and *Cx40*‐null mice are characterized by bundle branch block.[52](#jah32835-bib-0052){ref-type="ref"} Reduced expression of Cx40 in *Xirp2* ^−/−^ hearts might be a reason for the observed A‐V block. Supporting this hypothesis, we found that immunofluorescent intensity and size of Cx40 puncta were significantly reduced in the His‐bundle of *Xirp2* ^−*/*−^ hearts (Figure [8](#jah32835-fig-0008){ref-type="fig"}). Our results suggest that XIRP2 plays a role in the infranodal conduction system, and mutation of *XIRP2* could contribute to conduction defects.

![Confocal microscopy for hyperpolarization‐activated cyclic nucleotide‐gated K^+^ channel 4 (HCN4) localization and histological stains for acetylcholine esterase (AChE) activity and wheat germ agglutinin (WGA). P18 *Xirp2* ^*+/+*^ (top raw) and *Xirp2* ^−*/*−^ (bottom raw) hearts were serially cryosectioned. Adjacent serial 10‐μm sections were used for AChE activity stain (brown color) and for double‐label immunofluorescence with anti‐HCN4 (red color) and WGA stain (green color) to identify the atrioventricular (AV) node and to examine HCN4 expression level. a and e, AChE stain identifying the AV node. b and f, WGA stain outlining the tissue. c and g, HCN4‐positive region showing the AV node. d and h, Merged color images of HCN4 and WGA. c' and g', Zoom in the boxed areas in c and g, respectively. Bar in h=10 μm for a through h; bar in g′=10 μm for c' and g′.](JAH3-7-e006320-g007){#jah32835-fig-0007}

![Reduced expression of connexin 40 (Cx40) in the His‐bundle of *Xirp2* ^−*/*−^ hearts. Confocal microscopy of P18 *Xirp2* ^*+/+*^ (top raw) and *Xirp2* ^−*/*−^ (bottom raw) heart sections double labeling for Cx40 (red) and wheat germ agglutinin (WGA) (green). The adjacent section stained for acetylcholine esterase (AChE) was used to identify His‐bundles (data not shown). Panels b and d show the merged images. Box regions containing His‐bundles (His‐B) were zoomed in to show a significant reduction in Cx40 expression in *Xirp2* ^−*/*−^ heart (c' and d'), compared with *Xirp2* ^*+/+*^ heart (a′ and b′). Bar in d=40 μm for a through d; bar in d′=10 μm for a′ through d′.](JAH3-7-e006320-g008){#jah32835-fig-0008}

*Xirp2* ^−/−^ Ventricular Myocytes Exhibited Altered AP, Reduced I~TO~, and Increased I~K~ and I~K1~ {#jah32835-sec-0026}
----------------------------------------------------------------------------------------------------

Our previous studies showed that Xirp2 is required for normal ICD localization of Xirp1 and many other ICD components, such as N‐cadherin, desmoplakin, and Cx43,[31](#jah32835-bib-0031){ref-type="ref"}, [38](#jah32835-bib-0038){ref-type="ref"} and that Xirp1 can influence electrophysiological and conductive properties of ventricular myocytes.[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"} Taking together with the fact that both Xirp1 and Xirp2 are Xin repeats‐containing and ICD‐associated proteins, we hypothesized that Xirp2 would also play an important role in the electrophysiology of ventricular myocytes. Using the whole‐cell patch‐clamp technique in current‐clamp mode, we detected that the AP of *Xirp2* ^−/−^ ventricular myocytes had significantly increased AP amplitude, less negative maximal diastolic potential, and shorter APD at 20%, 50%, and 90% repolarization levels (APD20, APD50, and APD90), as compared with those obtained from *Xirp2* ^+/+^ cells (Figure [9](#jah32835-fig-0009){ref-type="fig"}B). Superimposing 2 traces together (Figure [9](#jah32835-fig-0009){ref-type="fig"}A) clearly demonstrated differences in depolarization and repolarization, and, more important, showed a rise in the resting membrane potential of *Xirp2* ^−/−^ myocytes, which suggests an easy initiation of the next AP wave.

![Action potential (AP) configurations of ventricular myocytes prepared from *Xirp2* ^*+/+*^ and *Xirp2* ^−*/*−^ mice. A, Representative tracings of AP waveforms in *Xirp2* ^*+/+*^ (left) and *Xirp2* ^−*/*−^ (middle) ventricular myocytes driven electrically. Superimposed comparison (right) reveals differences in AP configurations. B, Comparison of AP characteristics between the *Xirp2* ^*+/+*^ (black boxplots) and *Xirp2* ^−*/*−^population (gray box plots): on each box, the central mark is the median, the edges of the box are the 25th and 75th percentiles, and the whiskers extend to the most extreme data points. Significant changes in AP characteristics of *Xirp2* ^−*/*−^ ventricular myocytes. APA indicates AP amplitude; MDP, maximal diastolic potential. APD20, APD50, and APD90: APD measured at 20%, 50%, and 90% repolarization, respectively. \**P*\<0.05, significant difference between *Xirp2* ^+/+^ and *Xirp2* ^−/−^ myocytes. n, number of myocytes tested.](JAH3-7-e006320-g009){#jah32835-fig-0009}

To further understand mechanisms accounting for the altered AP waveform in *Xirp2* ^−/−^ myocytes, the whole‐cell patch‐clamp technique in voltage‐clamp mode was used to measure membrane ionic currents. As shown in Figure [10](#jah32835-fig-0010){ref-type="fig"}A (panel c), the I~Na~ current densities of *Xirp2* ^−/−^ myocytes at tested voltages were not significantly different from that of *Xirp2* ^+/+^ myocytes; thus, the I~Na~ current alone cannot account for the observed increased AP amplitude in *Xirp2* ^−/−^ myocytes. This finding is in contrast to our previous report[29](#jah32835-bib-0029){ref-type="ref"} that *Xirp1* ^−/−^ myocytes had significantly increased I~Na~ current density. On the other hand, depressed I~TO~ currents and current densities were detected in *Xirp2* ^−/−^ myocytes at pulsed voltages from +20 to +60 mV (Figure [10](#jah32835-fig-0010){ref-type="fig"}B). The I~TO~ plays a critical role for the early phase of repolarization in myocytes,[53](#jah32835-bib-0053){ref-type="ref"} and the decrease in the I~TO~ may contribute partly to the observed increase in AP amplitude of *Xirp2* ^−/−^ myocytes. Another outward delayed rectifier, I~K~, can affect the duration of the repolarization of an AP. As shown in Figure [10](#jah32835-fig-0010){ref-type="fig"}C, significant increases in amplitudes and current densities of I~K~ were detected in *Xirp2* ^−/−^ myocytes compared with control cells. Given that the I~K~ currents contribute to the delayed phase of repolarization of AP,[53](#jah32835-bib-0053){ref-type="ref"} the increase in I~K~ current density likely led to the observed decrease in APD50 and APD90 in *Xirp2* ^−/−^ myocytes. In addition to I~TO~ and I~K~, inward rectifier I~K1~ current maintains resting membrane potential and contributes to the terminal phase of repolarization.[53](#jah32835-bib-0053){ref-type="ref"} As shown in Figure [10](#jah32835-fig-0010){ref-type="fig"}D, significant increases in this I~K1~ inward currents and current densities at negative voltage from −70 to −120 mV were observed in *Xirp2* ^−/−^ myocytes compared with control cells.

![Various voltage‐dependent ionic currents in ventricular myocytes isolated from *Xirp2* ^*+/+*^ and *Xirp2* ^−*/*−^ mice. A, Inward Na^+^ current (I~N~ ~a~) densities. A series of I~N~ ~a~ currents were elicited on depolarization from a holding potential of −120 mV to testing potential from −80 to +60 mV for 40 ms in 1 *Xirp2* ^*+/+*^ (a) and 1 *Xirp2* ^−*/*−^ (b) ventricular myocyte. Size scales and clamp protocol are shown below *Xirp2* ^+/+^ tracings. (c) summarizes current density‐voltage relationships of I~N~ ~a~ in 2 groups of myocytes. n, number of myocytes tested. B, Transient outward K^+^ current (I~TO~) densities. Membrane currents were elicited on depolarization from a holding potential of −80 to −40 mV for 30 ms and then to test potentials from −40 to +60 mV for 300 ms. Examples of I~TO~ currents (indicated by triangle) recorded from 1 *Xirp2* ^*+/+*^ (a) and 1 *Xirp2* ^−*/*−^ (b) ventricular myocyte. Size scales and clamp protocol are shown below *Xirp2* ^+/+^ tracings. (c) summarizes current density‐voltage relationships of I~TO~ in 2 groups of myocytes. n, number of myocytes tested. \**P*\<0.05, significant difference. C, Delayed rectifier outward K^+^ current (I~K~) densities. A series of I~K~ currents were elicited on depolarization from a holding potential of −40 mV to a test potential from −40 to +60 mV for 1000 ms. Examples of I~K~ currents (indicated by triangle) recorded from 1 *Xirp2* ^*+/+*^ (a) and 1 *Xirp2* ^−*/*−^ (b) ventricular myocyte. Size scales and clamp protocol are shown below *Xirp2* ^+/+^ tracings. (c) summarizes current density‐voltage relationships of I~K~ in 2 groups of myocytes. n, number of myocytes tested. \**P*\<0.05, significant difference. D, Ba^2+^‐sensitive inward rectifier K^+^ current (I~K~ ~1~) densities. A series of I~K~ ~1~ currents were elicited on depolarization from a holding potential of −40 mV to a test potential from −20 to −120 mV for 1000 ms in 1 *Xirp2* ^*+/+*^ (a) and 1 *Xirp2* ^−*/*−^ (b) ventricular myocyte. Size scales and clamp protocol are shown below *Xirp2* ^+/+^ tracings. (c) summarizes current density‐voltage relationships of I~K~ ~1~ in 2 groups of myocytes. The difference in current densities before and after Ba^2+^ treatment was plotted against the test potentials to obtain current density‐voltage relationships. n, number of myocytes tested. \**P*\<0.05; \*\**P*\<0.01; significant difference.](JAH3-7-e006320-g010){#jah32835-fig-0010}

Xirp2 Is Associated With Both Nav1.5 and Kv1.5 {#jah32835-sec-0027}
----------------------------------------------

Ion channels interact with structural proteins for trafficking, stability, and function. A fraction of Nav1.5 (α‐subunit of I~Na~ channel) and Kv1.5 (α‐subunit of I~k,slow1~, 1 of the delayed rectifier I~K~ channels) are targeted to ICDs.[54](#jah32835-bib-0054){ref-type="ref"}, [55](#jah32835-bib-0055){ref-type="ref"} Co‐IP from mouse heart lysates showed that both anti‐Kv1.5 and anti‐Nav1.5 co‐pelleted Xirp2, but neither Xirp1‐S (small variant/previously called mXinα)[20](#jah32835-bib-0020){ref-type="ref"} nor Xirp1‐L (long variant/previously called mXinα‐a)[20](#jah32835-bib-0020){ref-type="ref"} (Figure [11](#jah32835-fig-0011){ref-type="fig"}A). On the other hand, anti‐Kv4.2 and control anti‐GAPDH antibodies did not pellet any Xirp proteins. Contrarily, when co‐IP experiments were performed with anti‐Xirp, both Kv1.5 and Nav1.5 were clearly immunoprecipitated with U1040 antibody (specific for Xirp2) against the peptide fragment from aa\# 3255 to 3278 of Xirp2,[31](#jah32835-bib-0031){ref-type="ref"} but not with U1697 antibody (specific for Xirp1) against the peptide fragment from aa\# 564 to 588 of Xirp1,[28](#jah32835-bib-0028){ref-type="ref"} U1013 antibody specific for all Xirp,[28](#jah32835-bib-0028){ref-type="ref"} or control anti‐GAPDH antibody (Figure [11](#jah32835-fig-0011){ref-type="fig"}B). Interestingly, U1013 anti‐Xirp antibody raised against Xirp1 fragment (aa\# 1--532) also cross‐reacted with Xirp2 (Figure [11](#jah32835-fig-0011){ref-type="fig"}A) in western blot, but it did not co‐pellet Nav1.5 or Kv1.5 (lane 5 of Figure [11](#jah32835-fig-0011){ref-type="fig"}B). Although the exact reason for this failure of co‐IP remains unclear, a weak cross‐reactivity of U1013 to Xirp2 or/and a lesser amount of antigen Xirp2 as compared with Xirp1 in total lysate may greatly reduce the sensitivity in this assay. Alternatively, binding of U1013 to the highly conserved region of Xin repeats in Xirp2 may disrupt potential interactions between this region and the Kv1.5/Nav1.5. On the other hand, the epitopes recognized by U1040 are located at the extreme C‐terminus of Xirp2, which may not be required for Xirp2 to interact with Kv1.5 and Nav1.5.

![Co‐immunoprecipitation (Co‐IP) experiments. A, Co‐IPs were performed with various antibodies against α‐subunits of different channels to examine the possible associations between XIRP and channel components. Total lysates (lane 1) and clarified supernatants as inputs (lane 2) were prepared from adult wild‐type mouse hearts as described under Methods. The aliquot of input was used for immunoprecipitation (IP) with various primary antibodies cross‐linked to Dynabeads protein G. The primary antibodies included rabbit anti‐Kv1.5 (lane 3), rabbit anti‐Nav1.5 (lane 4), mouse anti‐Kv4.2 (lane 5), and rabbit anti‐GAPDH (lane 6). The resulting immunoprecipitates were fractionated and immunoblotted with rabbit anti‐Xirp1 (U1013) antibody that recognized both Xirp1‐S (small isoform), Xirp‐L (large isoform), and Xirp2. Xirp2 was co‐pelleted in the immunoprecipitates with anti‐Kv1.5 and with anti‐Nav1.5, but neither with anti‐Kv4.2 nor with anti‐GAPDH. B, Reverse Co‐IPs were performed with cross‐linked rabbit antibody U1697 (specific to Xirp1), U1040 (specific to Xirp2), U1013 (cross‐reacted to both Xirp1 and Xirp2), or anti‐GAPDH antibody. The resulting immunoprecipitates were immunoblotted with anti‐Kv1.5 (lower panel), anti‐Nav1.5 (top panel), or anti‐Kv4.2 (data not shown). Both Kv1.5 and Nav1.5 are co‐pelleted in the immunoprecipitates with anti‐Xirp2 U1040 antibody.](JAH3-7-e006320-g011){#jah32835-fig-0011}

Discussion {#jah32835-sec-0028}
==========

Mouse *Xirp* Genes Are Critical for Cardiac Conduction {#jah32835-sec-0029}
------------------------------------------------------

Our previous studies have clearly demonstrated that mouse hearts without Xirp1 led to disrupted ICD, hypertrophy, and cardiomyopathy with conduction defects.[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"}, [30](#jah32835-bib-0030){ref-type="ref"} In the present study, we have further shown that *Xirp2*‐null hearts also exhibit cardiac conduction defects (ie, slower conduction velocity, A‐V block, and prolonged QT interval). Xin repeat‐containing protein family, Xirp1 and Xirp2, function as scaffolding proteins to interact with components of actin cytoskeleton, N‐cadherin‐mediated junction, and ionic channel assembly.[1](#jah32835-note-1005){ref-type="fn"} Therefore, Xirp proteins play essential roles in regulating not only the ICD structure and function, but also the surface expression of ion channels, influencing action potential propagation in the heart. Xirp2 initiates the formation of ICD and localizes Xirp1 to ICD, whereas Xirp1 can further stabilize and maintain ICD integrity. Significant proportions of key ion‐channel assemblies required for controlling AP have been shown to localize to ICDs through their scaffolding or anchoring proteins,[36](#jah32835-bib-0036){ref-type="ref"}, [37](#jah32835-bib-0037){ref-type="ref"}, [54](#jah32835-bib-0054){ref-type="ref"}, [55](#jah32835-bib-0055){ref-type="ref"}, [56](#jah32835-bib-0056){ref-type="ref"} and defects in these localization processes can lead to arrhythmias and cardiac sudden death.[56](#jah32835-bib-0056){ref-type="ref"}

Cardiac conduction defects observed in *Xirp2*‐null mice may account for the pathogenesis of the nonsense variant (Q2875\*) and frameshift variant (T2238QfsX7) in *XIRP2* from SUNDS and BrS, respectively. Both variants contain premature termination codon, which could cause nonsense‐mediated mRNA decay, a universal mRNA degradation pathway in eukaryotes that monitors and eliminates abnormal mRNAs to avoid the generation of harmful proteins.[42](#jah32835-bib-0042){ref-type="ref"}, [43](#jah32835-bib-0043){ref-type="ref"}, [44](#jah32835-bib-0044){ref-type="ref"} Nonsense‐mediated mRNA decay has been reported in long QT syndrome patients attributed to *hERG* nonsense mutations[57](#jah32835-bib-0057){ref-type="ref"} and a BrS patient attributed to a *CACNA1C* splicing mutation.[43](#jah32835-bib-0043){ref-type="ref"} Therefore, the Q2875\* nonsense variant and the T2238QfsX7 frameshift variant would likely induce nonsense‐mediated mRNA decay and express a reduced amount of XIRP2, which could contribute to the No. E78 SUNDS case and the No. ZS116 BrS case, respectively.

*XIRP1* and *XIRP2* Represent Class of Novel Susceptible Genes for Human Cardiac Arrhythmias Disorders With Conduction Defect Such as SUNDS and BrS {#jah32835-sec-0030}
---------------------------------------------------------------------------------------------------------------------------------------------------

In this study, we provided the following experimental evidences to support that both *XIRP1* and *XIRP2* are novel susceptible genes for SUNDS and BrS. First, we showed that SUNDS and BrS cases unexplained by variants in 39 known arrhythmia‐susceptibility genes are enriched with rare variants in *XIRP1* and *XIPR2*. Some of these variants affect highly conserved regions of the XIRP1 and XIRP2 proteins and many of them are predicted to be deleterious by in silico prediction tools. Next, with a mouse model, we showed that (1) Xirp2 is strongly expressed in the ventricular conduction system; (2) *Xirp2* ^−/−^ mice exhibit slow conduction velocity, prolonged PR and QT intervals, and A‐V conduction block; (3) loss of Xirp2 leads to reduced activity or expression of markers for the ventricular conduction system, including AChE and Cx40; and (4) *Xirp2* ^−/−^ ventricular myocytes have altered AP configuration and changes in membrane ionic currents. Finally, we showed that Xirp2 is associated with important cardiac ion channel components, Nav1.5 and Kv1.5. Collectively, this evidence, together with our previous findings that Xirp1 regulates surface expression of I~To~ and I~K~ channels,[27](#jah32835-bib-0027){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"}, [36](#jah32835-bib-0036){ref-type="ref"} strongly supports the overall concept that *XIRP1* and *XIRP2*, encoding 2 ICD‐associated proteins, are important for cardiac electrophysiology and that they constitute a novel family of candidate genes for cardiac arrhythmia disorders, including SUNDS and BrS.

SUNDS, a clinical conundrum in both forensic and clinical medicine, has a strong genetic underpinning based on reported molecular pathological studies.[3](#jah32835-bib-0003){ref-type="ref"}, [14](#jah32835-bib-0014){ref-type="ref"}, [15](#jah32835-bib-0015){ref-type="ref"}, [16](#jah32835-bib-0016){ref-type="ref"}, [17](#jah32835-bib-0017){ref-type="ref"}, [18](#jah32835-bib-0018){ref-type="ref"}, [19](#jah32835-bib-0019){ref-type="ref"} Accumulated evidence suggests that SUNDS is related primarily to cardiac arrhythmia diseases, such as BrS,[58](#jah32835-bib-0058){ref-type="ref"} long QT syndrome,[59](#jah32835-bib-0059){ref-type="ref"} sick sinus syndrome,[60](#jah32835-bib-0060){ref-type="ref"} and cardiac conduction disease.[61](#jah32835-bib-0061){ref-type="ref"} However, we have previously shown that in a Chinese Han population, genetic variants in 39 arrhythmia‐associated genes could only possibly account for a small part of sporadic SUNDS cases,[14](#jah32835-bib-0014){ref-type="ref"}, [15](#jah32835-bib-0015){ref-type="ref"}, [16](#jah32835-bib-0016){ref-type="ref"}, [17](#jah32835-bib-0017){ref-type="ref"}, [18](#jah32835-bib-0018){ref-type="ref"}, [19](#jah32835-bib-0019){ref-type="ref"} suggesting the existence of unknown susceptible genes. In this study, we identified 20 rare variants (8 were in silico predicted as deleterious; Tables [1](#jah32835-tbl-0001){ref-type="table-wrap"} and [2](#jah32835-tbl-0002){ref-type="table-wrap"}) in *XIRP1* and *XIRP2* genes of SUNDS and BrS cases, and all of these rare variants were found either absent or less frequent in Chinese Han, and East Asian from a local database, 1000 Genomes Project Phase 3, ExAC, and gnomAD data sets.

How Do Identified Rare Variants Contribute to Pathogenesis of SUNDS and BrS? {#jah32835-sec-0031}
----------------------------------------------------------------------------

Variants altering the function of XIRP1 and XIRP2 could cause cardiac electrophysiology defects by several mechanisms. We have reported that Xirp1 regulates the I~TO~ and I~K~ channels by directly interacting with KChIP2, filamin, and cortactin.[27](#jah32835-bib-0027){ref-type="ref"}, [36](#jah32835-bib-0036){ref-type="ref"} *Xirp1*‐null cardiomyocytes have prolonged APD, alterations in ionic currents, and increased incidence of early afterdepolorization, and *Xirp1*‐null hearts show prolonged QT interval and conduction defects.[27](#jah32835-bib-0027){ref-type="ref"}, [28](#jah32835-bib-0028){ref-type="ref"}, [29](#jah32835-bib-0029){ref-type="ref"} In the current study, we further showed that Xirp2 is required for the formation of infranodal ventricular conduction system and normal AP configuration; and that Xirp2 is associated with Nav1.5 and Kv1.5. Therefore, variants in Xirp1 or Xirp2 may disrupt their interaction with the channel complexes and lead to dysregulation of channel functions. Interaction between ion channels and cytoskeletal proteins are important for their trafficking, stability, and function. For example, Nav1.5 E1053K variant causes BrS by blocking the interaction between Nav1.5 and cytoskeletal protein Ankyrin‐G, leading to significant reduction of Nav1.5 at the T‐tubules and ICDs.[62](#jah32835-bib-0062){ref-type="ref"} Our co‐IP results suggest that Xirp2 could be important for localizing Nav1.5 and Kv1.5 to ICDs.

Furthermore, the rare variants we identified in *XIRP1* and *XIRP2* may modulate the electrophysiological properties of cardiomyocytes by regulating ICD maturation and maintenance. ICDs are a unique structure to the heart and they contain cell‐cell junctions for mechanical and electrical coupling. ICDs also harbor voltage‐gated sodium channels and potassium channels.[63](#jah32835-bib-0063){ref-type="ref"} Accumulated evidence suggests that the cell‐cell junctions at ICDs modulate ionic currents.[36](#jah32835-bib-0036){ref-type="ref"}, [37](#jah32835-bib-0037){ref-type="ref"}, [64](#jah32835-bib-0064){ref-type="ref"}

Finally, it is possible that the rare variants we identified in *XIRP2* may cause defects in the ventricular conduction system. The *Xirp* gene family is a downstream target of Nkx2‐5,[25](#jah32835-bib-0025){ref-type="ref"}, [50](#jah32835-bib-0050){ref-type="ref"}, [65](#jah32835-bib-0065){ref-type="ref"}, [66](#jah32835-bib-0066){ref-type="ref"} and it is well established that Nkx2‐5 plays an important role in the development of the ventricular conduction system and variants in Nkx2‐5 cause A‐V blocks.[67](#jah32835-bib-0067){ref-type="ref"}

Five In Silico--Predicted Deleterious Rare Variants Identified in This Study Are Located to Highly Conserved Regions of XIRP Proteins {#jah32835-sec-0032}
-------------------------------------------------------------------------------------------------------------------------------------

In addition to a nonsense variant (Q2875\*) and a frameshift variant (T2238QfsX7) discussed above, 5 missense rare variants (A930V, E215K, E737K, I1899N, and L2718P) identified in this study intrigued us to speculate on their pathogenic role in patients. Among these in silico--predicted deleterious variants, XIRP2 E215K and XIRP2 L2718P were absent from ExAC, gnomAD, and database of single‐nucleotide polymorphism and were defined as novel. XIRP1 A930V, XIRP2 I1899N, and XIRP2 L2718P variants were located to the highly conserved regions immediately after the Xin repeats of both XIRP proteins.[26](#jah32835-bib-0026){ref-type="ref"} In contrast, XIRP2 E215K variant was located at the N‐terminal region of XIRP2 protein. This conserved N‐terminal sequence was only found in the Xirp2 proteins from humans and primates.[26](#jah32835-bib-0026){ref-type="ref"}

XIRP1 A930 is a highly conserved residue among multiple mammalian species[26](#jah32835-bib-0026){ref-type="ref"} and its surrounding sequence is homologous to the XIRP2 region[26](#jah32835-bib-0026){ref-type="ref"} harboring the V1743I polymorphism (Table [S3](#jah32835-sup-0001){ref-type="supplementary-material"}). In silico software predicted that A930V might alter actin cytoskeleton dynamics. Supporting this prediction, the V1743I polymorphism and A930V variant are located within the regions homologous to an α‐actinin‐binding site in mouse Xirp2.[50](#jah32835-bib-0050){ref-type="ref"} We proposed that the A930V variant is most probably the genetic cause of the No. E128 SUNDS case, but the biophysical mechanisms should be elucidated by future electrophysiological, biochemical, and functional studies. Within this highly conserved region, we also identified a XIRP1 Q856R variant from a SUNDS case and a XIRP2 R1715H variant from a BrS case (Figure [2](#jah32835-fig-0002){ref-type="fig"}).

The novel XIRP2 E215K variant led to the replacement of glutamic (E) by lysine (K) at the N‐terminus of XIRP2 and was in silico predicted as a deleterious variant. The N‐terminal sequence from aa\#1 to \#222 of human (also chimpanzee and rhesus monkey) XIRP2 is not found in mouse and chicken Xirp2 proteins, and therefore this region is primate specific.[26](#jah32835-bib-0026){ref-type="ref"} It should be noted that within this primate‐specific region, we found a total of 3 rare variants (V51A, S52L, and E215K) associated with SUNDS cases (Figure [2](#jah32835-fig-0002){ref-type="fig"}).

XIPR2 E737K is located in 1 of the highly conserved Xin repeats of XIPR2, and therefore this variant may interfere with the interaction between Xirp2 and actin filaments.

The novel XIRP2 L2718P variant is located very close to XIRP2 Q2875\* variant within the conserved sequence region at C‐terminus of all Xirp2 examined, which is, however, not found in all Xirp1 examined.[26](#jah32835-bib-0026){ref-type="ref"} In the current study, we have shown that Xirp2, but not Xirp1, is capable of associating with Nav1.5 and Kv1.5 (Figure [11](#jah32835-fig-0011){ref-type="fig"}). Although the interacting sites for Nav1.5 and Kv1.5 have not been mapped on XIRP2, this conserved C‐terminal region may possess such sites. If it is proven to be true, this novel variant could interfere with the interactions and then affect I~Na~ and I~K~ channel activities.

Within the conserved C‐terminus of XIRP2, there exists a sequence (aa\#3201--3229) highly homologous to consensus NLS. The importance of this NLS in XIRP2 was suggested by the identification of a missense variant R3223H within the NLS, a nonsense variant Q2875\*, and a frameshift variant T2238QfsX7. These variants might be able to either disrupt or delete this NLS signal and then affect normal XIRP2\'s function. However, the exact functions of R3223 in XIRP2 will need to be experimentally studied.

The predicted functional defects in all 20 rare variants of XIRP were summarized in Table [S5](#jah32835-sup-0001){ref-type="supplementary-material"}. Together with all findings above, we proposed that all these identified *XIRP* rare variants in both SUNDS and BrS may contribute to the corresponding SUNDS or BrS cases (Tables [1](#jah32835-tbl-0001){ref-type="table-wrap"} and [2](#jah32835-tbl-0002){ref-type="table-wrap"}).

Study Limitations {#jah32835-sec-0033}
-----------------

The relatively small sample size for genetic testing as well as the absence of clinic information (for SUNDS) and genetic investigation of family members (for both SUNDS and BrS) limited a precise assessment of linkage between clinic and genetic phenotypes.

Although our data from mouse *Xirp* knockout studies support that Xirp proteins are important in conduction system and ion channel functions, direct characterization of mice carrying these *XIRP* variants to be established by CRISPR technology is still needed to define their causal roles in SUNDS and BrS cases.

Conclusions {#jah32835-sec-0034}
===========

Despite several study limitations, this first report identifying likely pathogenic XIRP rare variants in BrS cases and in the largest SUNDS cohort reported provided molecular and pathological evidences that XIRP rare variants may contribute to the genetic cause of arrhythmogenic disorders such as SUNDS and BrS.
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